Targeted disruption of CD38 accelerates autoimmune diabetes in NOD/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion.

Source:http://linkedlifedata.com/resource/pubmed/id/16585549

J. Immunol. 2006 Apr 15 176 8 4590-9

Download in:

View as

General Info

PMID
16585549